Literature DB >> 20598067

Allergic rhinitis in children.

Paul J Turner1, Andrew S Kemp.   

Abstract

Allergic rhinitis affects up to 40% of children but is commonly undiagnosed. Careful assessment of nasal symptoms allows for the most appropriate therapeutic options to be chosen. Allergen avoidance is often difficult in practice. Antihistamines are of limited benefit in allergic rhinitis caused by house dust mite and other perennial allergens, where symptoms, predominantly nasal obstruction, are not histamine mediated. In contrast, symptoms triggered by pollen, such as nasal itch, rhinorrhoea and sneezing, are relieved by antihistamines. Intranasal steroids are the treatment of choice for persistent moderate-severe allergic rhinitis and are more effective than antihistamines for relief of nasal obstruction. Failure to respond to intranasal medications is often caused by poor compliance or inefficient use of nasal sprays. Immunotherapy may be a useful, if expensive, option, particularly where symptoms are because of a specific pollen. The benefits of immunotherapy in house dust mite-induced rhinitis and asthma remain controversial.
© 2010 The Authors. Journal compilation © 2010 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Mesh:

Year:  2010        PMID: 20598067     DOI: 10.1111/j.1440-1754.2010.01779.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  4 in total

1.  Allergic Rhinitis in Children: A Randomized Clinical Trial Targeted at Symptoms.

Authors:  Nicola Mansi; Gabriele D'Agostino; Antonella Silvia Scirè; Giada Morpurgo; Dario Gregori; Achal Gulati; Valerio Damiani
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-02-11

2.  Allergic rhinitis and its associated co-morbidities at Bugando Medical Centre in Northwestern Tanzania; A prospective review of 190 cases.

Authors:  Said A Said; Mabula D Mchembe; Peter Rambau; Japhet M Gilyoma; Phillipo L Chalya
Journal:  BMC Ear Nose Throat Disord       Date:  2012-11-08

3.  Reasons for prescribing second generation antihistamines to treat allergic rhinitis in real-life conditions and patient response.

Authors:  Pascal Demoly; Anca Mirela Chiriac; Benoît Berge; Michel Rostin
Journal:  Allergy Asthma Clin Immunol       Date:  2014-06-06       Impact factor: 3.406

Review 4.  HMGB1 in the Pathogenesis of Nasal Inflammatory Diseases and its Inhibition as New Therapeutic Approach: A Review from the Literature.

Authors:  Luisa Maria Bellussi; Serena Cocca; Giulio Cesare Passali; Desideri Passali
Journal:  Int Arch Otorhinolaryngol       Date:  2017-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.